Navigation Links
CTD Holdings, Inc. Announces Refinancing of Long Term Debt
Date:8/8/2013

Alachua, Florida (PRWEB) August 08, 2013

CTD Holdings, Inc. (OTCQB:CTDH) closed on a series of loans through Regions Bank that refinances its existing indebtedness into three notes at favorable interest rates. The three notes consist of: a Mortgage on the company's Alachua, FL property of $578,998 with an interest rate of 3.99%; an Equipment Loan of $295,890 secured by a lien on the company's manufacturing equipment with an interest rate of 3.99%; and a Line of Credit for $100,000 with an interest rate of prime plus 1.8% currently 5.05%. A complete description of the loan package is found in the SEC Form 8K filed July 26, 2013.

This new lending facility with Regions Bank positions the company for continued future growth by improving monthly cash flow, reducing the effective interest rate on the Company’s debt by more than 2%, and extending the maturity of the debt. Regions Bank is a strong banking partner able to meet the Company’s larger and more complicated banking service needs as it grows.

“We are delighted to establish a primary banking relationship with Regions Bank.” stated CTD Holdings President, Dr. Jeffrey Tate, “Regions is well positioned to provide the level of service and banking support our Company will need as we continue to grow.”

As part of the loan package, CTD Holdings has agreed to make Regions Bank home for its primary operation accounts.

“The improved cash flow and reduced borrowing costs mean the Company is now better positioned to invest in new products and sales activities.” said CTD Holdings Director of Operations, Mr. Kevin Strattan.

CTD Holdings is currently upgrading its internet eCommerce site and developing ultra pure products for cosmetic, cell culture and pharmaceutical applications.

About the Company: 

The CTD Holdings, Inc. Family of Companies manufacture and market Trappsol and Aquaplex cyclodextrins and cyclodextrin complexes for food, nutrition and pharmaceutical markets. NanoSonic Products, Inc. operates the world's only cGMP pulse drying facility for the production of pharmaceutical grade Aquaplex cyclodextrin complexes. The companies offer a wide variety of cyclodextrin related manufacturing services to its worldwide customers; including custom formulation, manufacturing, and commercial scale supply of pharmaceutical grade cyclodextrin complexes. For additional information, visit the Company's website.

Safe Harbor Statement:

This press release contains "forward-looking statements" about the Company's current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as "anticipates," "believes" and "expects" or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual results in future periods to differ materially from what is expressed in, or implied by, these statements. The factors which may influence the Company's future performance include the Company's ability to obtain additional capital to expand operations as planned, success in attracting additional customers and profitable contracts, and regulatory risks associated with producing food and pharmaceutical grade products. These and other risk factors are described from time to time in the Company's filings with the Securities and Exchange Commission, including, but not limited to, the Company's reports on Forms 10-K and 10-Q. Unless required by law, the Company assumes no obligation to update or revise any forward-looking statements as a result of new information or future events.

Read the full story at http://www.prweb.com/releases/CTDHoldingsInc/LoanPackage8K/prweb11002183.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Bacterin International Holdings, Inc. Schedules Fourth Quarter 2011 Financial Earnings Conference Call
2. Innophos Holdings, Inc. Reports First Quarter 2012 Results
3. China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2012 Financial Results on May 15, 2012
4. Inclinix-PMG Holdings, Inc. Announces Executive Management Changes
5. Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
6. Aveka Nutra Processing proudly begins producing products from Z Trim Holdings, Inc.
7. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
8. Z Trim Holdings, Inc. adds non-GMO corn products to its product line
9. Z Trim Holdings, Inc. Enters into Joint Development Agreement with Drilling Fluids Company
10. Z Trim Holdings, Inc. Records First Non-GMO Corn Sales
11. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2019)... , ... May 14, 2019 , ... Gateway Genomics ... effectively doubling its space from 2,500 to 5,000 square feet. , “This past ... DNA tests ,” says Gateway Genomics CEO, Chris Jacob. “The SneakPeek At-Home test, which ...
(Date:5/4/2019)... BROOK, N.J. (PRWEB) , ... May 03, 2019 ... ... electrophysiology, announces the release of the Diopsys® ffERG/Photopic Negative Response vision ... of glaucoma. , By 2050, it is estimated that 6.3 million Americans will ...
(Date:5/2/2019)... VIEJO, Calif. (PRWEB) , ... May 02, 2019 ... ... leading clinical genetics testing company, will present results documenting discrepancies between U.S. insurer ... management guidelines for patients at risk for hereditary breast and ovarian cancer (HBOC). ...
(Date:4/18/2019)... ... 18, 2019 , ... Taking a step closer to a ... at Worcester Polytechnic Institute (WPI) has developed a novel process using an unusual ... and other biofuels more economically. , Isobutanol, like ethanol, is an alcohol, but ...
Breaking Biology Technology:
(Date:4/25/2019)... ... 23, 2019 , ... In recent years the neurocognitive effects ... in many cases the magnitude of these deficits and the long-term impact on ... neurocognitive effects may impact developmental trajectories, and patients are often so unwell at ...
(Date:4/25/2019)... ... April 24, 2019 , ... In a ... today, a broad collective of 62 individual scientists, bioethicists, and biotechnology executives, including ... & Cell Therapy (ASGCT), across industry and academia called for collaboration on a ...
(Date:4/25/2019)... WEST CHESTER, Ohio (PRWEB) , ... April 25, ... ... and research agents, as well as screening tools, has strengthened its commitment to ... Aprotinin can be used in any application where inhibition of its targeted proteases ...
Breaking Biology News(10 mins):